ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Jefferies Hits Refiners; WST Gets Rare Upgrade

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Jefferies analyst Lloyd Byrne cut both MPC and VLO to Hold from Buy on Monday. The twin downgrades signal a souring view on US refining margins. Marathon Petroleum carries a $113B market cap. Valero is similarly sized at $113B. Byrne set a $413 target on Marathon and $401 on Valero. Neither stock carries heavy short interest — SI sits below 3.5% of free float for both — suggesting short sellers have not yet piled in behind the analyst call.

Elsewhere, WST — West Pharmaceutical Services — received a rare upgrade from consensus. The drug packaging specialist has a $25B market cap. Its new average target price of $407.56 compares to the prior $405.38. Short interest on WST is just 3.1% of free float, and availability is extremely high at 3,701% of SI, meaning very few bears are positioned against it.

Jefferies also raised its target on META to $875 — well above the consensus average of around $710. Analyst Brent Thill kept his Buy rating. META commands 56 Buy ratings versus just six Holds. MSFT also saw its consensus target nudged higher to $576.

Stocks in this article

How this article was generated

Generated
22 Sept 2026, 16:20
Prompt version
v1.0
Data sources
Analyst consensus

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.